CN104744285A - Synthesis method for dioctyl phthalate hapten and artificial antigen and application thereof - Google Patents

Synthesis method for dioctyl phthalate hapten and artificial antigen and application thereof Download PDF

Info

Publication number
CN104744285A
CN104744285A CN201410336147.8A CN201410336147A CN104744285A CN 104744285 A CN104744285 A CN 104744285A CN 201410336147 A CN201410336147 A CN 201410336147A CN 104744285 A CN104744285 A CN 104744285A
Authority
CN
China
Prior art keywords
dehp
reaction
artificial antigen
concentrated
haptens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410336147.8A
Other languages
Chinese (zh)
Other versions
CN104744285B (en
Inventor
张挺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou City Polytechnic
Original Assignee
Guangzhou City Polytechnic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou City Polytechnic filed Critical Guangzhou City Polytechnic
Priority to CN201410336147.8A priority Critical patent/CN104744285B/en
Publication of CN104744285A publication Critical patent/CN104744285A/en
Application granted granted Critical
Publication of CN104744285B publication Critical patent/CN104744285B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention discloses a synthesis method for a dioctyl phthalate hapten and an artificial antigen and application thereof, and belongs to the technical field of immunological detection. The synthesis method disclosed by the invention comprises the following steps: preparing an intermediate product containing an amino group from DEHP used as a raw material through a nitration reaction and a reduction reaction, and then reacting with a reagent such as a halogenated acid salt to generate the hapten with a carboxyl group; and then coupling with proteins to prepare the artificial antigen through an active lipid method or a mixed anhydride method. The artificial antigen can be used for preparing an anti-DEHP specific antibody in animal immunization, and has important practical significance on establishment for an ELISA analysis method for detecting DEHP.

Description

A kind of dioctyl phthalate (DOP) haptens and synthesizing artificial antigen and application thereof
Technical field
The present invention relates to technical field of immunological detection, in particular, the present invention relates to a kind of dioctyl phthalate (DOP) haptens and synthesizing artificial antigen and application thereof.
Background technology
Phthalic acid two (α-ethyl hexyl) ester (Di (2-ethylhexyl) phthalate), english abbreviation DEHP, have another name called dioctyl phthalate (DOP), molecular weight is 390.5, these product solubleness <0.01% in water when 25 DEG C, be dissolved in most of organic solvent and hydro carbons, its structural formula is:
DEHP belongs to phthalate fluidizer, is a kind of industrial raw material, is to use the widest and that output is maximum fluidizer at present.DEHP can by food and water absorb, the food contacted with containing DEHP container also can be polluted, and also has illegal manufacturer to it can be used as additive for foodstuff production.
The World Health Organization points out that phthalate enters in human body and animal body and has similar estrogenic effect, meeting disturbance endocrine, endocrine disturbance can be caused, encumber organism Reproductive Performance, comprise reproduction rate reduction, miscarriage, congenital defect, abnormal sperm count, damage of testis, also can cause malignant tumour or cause teratogenesis.Clinical study shows to take or long-term exposure also can have significant impact for myocardial cell in DEHP, causes heart irregular rhythm.Therefore, DEHP belongs to violated industrial raw material in food.
To the detection of the phthalate fluidizer in food mainly based on physico-chemical analysis method (as GC-MS, HPLC).But during application instrumental method, its sensitivity is very large by the impact of the purification of sample, the step such as concentrated, and measuring method is complicated, loaded down with trivial details, detection flux is little, need cultivate professional personnel to detect, testing cost is expensive, can not realize the rapid detection analysis of batch samples.Therefore, simple and fast detection method easily is more necessary to develop.
Immunologic detection method, be one of important method of current food safety rapid detection, testing cost is very low, uses simple, is applicable to the selective mechanisms of a large amount of sample, in food safety detection, has played vital role.
Summary of the invention
The technical problem that the present invention solves is to provide a kind of dioctyl phthalate (DOP) haptens and synthesizing artificial antigen and application thereof, provides immunizing antigen and envelope antigen and antibody preparation to lay the foundation for setting up inspection-free detection method.
For solving the problems of the technologies described above, the present invention adopts following technical scheme:
The haptenic molecular structural formula of a kind of DEHP is:
N is the natural number of 1 ~ 6.
Described DEHP haptens is combined with carrier proteins, obtains DEHP artificial antigen, and its molecular structural formula is:
N is the natural number of 1 ~ 6; Described n is preferably 2; Described carrier proteins is bovine serum albumin, ovalbumin or hemocyanin.
The haptenic synthetic method of described DEHP, comprises the following steps:
(1) be that concentrated nitric acid and DEHP are placed in round-bottomed flask by 2:1 ~ 3:1 by feed ratio, be added drop-wise to 2 times under condition of ice bath in the vitriol oil of concentrated nitric acid amount, magnetic agitation, reacts to room temperature, then 60 DEG C of back flow reaction 5h, and period is monitored with TLC.With the sodium hydroxide solution neutralization reaction liquid of 1moL/L to weakly alkaline, extraction into ethyl acetate 3 times, organic phase evaporated under reduced pressure on Rotary Evaporators obtains thick nitration product DEHP-NO 2, cross silicagel column, collect elutriant to be V/V be the chloroform/hexanaphthene wash-out phase of 2:1 ~ 3:1, elutriant is concentrated into dry, obtains the nitration product DEHP-NO of purifying 2;
(2) be that 1:3:3 is by DEHP-NO by feed ratio 2, NH 4cl, iron powder are placed in round-bottomed flask, and add in 70% appropriate ethanolic soln, magnetic agitation, 50 DEG C of back flow reaction 5h, period is monitored with TLC; After reaction terminates, in reaction solution, add 100mL dehydrated alcohol, elimination iron powder, collect filtrate, concentrated near dry in Rotary Evaporators; In concentrated solution, add 30mL water, be extracted with ethyl acetate 3 times, collect organic phase, evaporate to dryness, obtains crude product DEHP-NH 2; Cross silicagel column, collect elutriant to be V/V be the chloroform/methanol wash-out phase of 5:1 ~ 4:1, elutriant is concentrated into dry, obtains the reduzate DEHP-NH of purifying 2;
(3) be that 1:2 ~ 1:3 is by DEHP-NH by feed ratio 2be placed in round-bottomed flask with halo hydrochlorate, and by a small amount of anhydrous alcohol solution of its mixture, add the salt of wormwood with halo hydrochlorate equivalent simultaneously, back flow reaction at 60 DEG C, appropriate potassiumiodide is added as catalyzer in reaction process, after return stirring reaction 5h, stopped reaction.Filter reaction mixture and obtain yellowish brown filtrate, concentrate and obtain brown color grease-like material.Cross silicagel column, collect elutriant to be V/V be the chloroform/methanol wash-out phase of 4:1 ~ 5:1, elutriant is concentrated into dry, obtains product and is target haptens.
Described concentrated nitric acid is the nitric acid of 65%, and halo hydrochlorate is halogenated acid sodium, and its structural formula is R-(CH 2) n-COONa, wherein R can be Cl or Br, n=1 ~ 6
The preparation method of described DEHP artificial antigen is active fat method and mixed anhydride method.
Described active ester method comprises the following steps:
(1) be dissolved in the DMF of 1mL by the DEHP haptens of 0.1mmol, then in this solution, add equimolar DCC and NHS, the reaction of room temperature lucifuge is spent the night;
(2) 4 DEG C of centrifugal segregation precipitations, get supernatant liquor, and it slowly joined in the carbonic acid buffer of 5mL pH9.5, its damping fluid contains carrier proteins BSA or OVA, and wherein the concentration of carrier proteins is 10 ~ 15mg/mL, reacts and spend the night at 4 DEG C;
(3) reaction solution in step (2) is loaded dialysis tubing, with the normal saline dialysis 3d of 0.9%, obtain artificial antigen.
Described mixed anhydride method comprises the following steps:
(1) be dissolved in 1mL DMF by 0.1mmol DEHP haptens, add the positive Tributylamine of 80 μ L, slowly drip 0.15mmol isobutyl chlorocarbonate under ice bath, 4 DEG C of stirring reaction 1h, this is first liquid;
(2) be dissolved in the sodium bicarbonate buffer liquid of 5mL1mol/L pH9.6 by 60mg carrier proteins BSA or OVA, this is second liquid;
(3) be slowly added drop-wise in second liquid by first liquid, 4 DEG C of magnetic agitation reactions are spent the night, and after question response completes, load dialysis tubing, then use the normal saline dialysis 3d of 0.9%, obtain artificial antigen.
Described DEHP artificial antigen can be applicable to the preparation preparing anti-DEHP polyclonal antibody or monoclonal antibody.
The invention has the beneficial effects as follows:
Because DEHP is small-molecule substance (molecular weight is less than 1000Da), itself does not possess immunogenicity, must be prepared as artificial antigen with high molecular weight protein coupling, and animal just can be made to produce antibody.Because DEHP itself does not possess active group, can not with high molecular weight protein coupling, therefore need to carry out molecular modification to DEHP, introducing-NH 2with-COOH isoreactivity group, synthesis DEHP haptens.The present invention take DEHP as raw material, obtains DEHP haptens with nitric acid, ammonium chloride, halogenated acid reactant salt; By active ester method or mixed anhydride method, DEHP haptens and carrier protein couplet are obtained DEHP artificial antigen, this artificial antigen can be used for the specific antibody that animal immune prepares anti-DEHP, to setting up the elisa assay method detecting DEHP, have important practical significance, be and set up inspection-free detection method and provide immunizing antigen and envelope antigen and antibody preparation to lay the foundation.
Embodiment
Embodiment 1
DEHP hapten synthesis
As n=1, route prepared by DEHP haptens is as follows:
4mL DEHP (10mmoL) and the concentrated nitric acid (20mmoL) of 1mL65% are placed in round-bottomed flask, add the 5mL vitriol oil under condition of ice bath, magnetic agitation, react to room temperature, then 60 DEG C of back flow reaction 5h, period is monitored with TLC.After reaction terminates, with the sodium hydroxide solution neutralization reaction liquid of 1moL/L to weakly alkaline, extraction into ethyl acetate 3 times, organic phase evaporated under reduced pressure on Rotary Evaporators obtains thick nitration product DEHP-NO 2, cross silicagel column, collect elutriant to be V/V be the chloroform/hexanaphthene wash-out phase of 2:1 ~ 3:1, elutriant is concentrated into dry, obtains the nitration product DEHP-NO of purifying 2.
1mmoL DEHP-NO 2, 3mmoLNH 4cl, 3mmoL iron powder is placed in round-bottomed flask, adds in the ethanolic soln of 20mL70%, magnetic agitation, and 50 DEG C of back flow reaction 5h, period is monitored with TLC.After reaction terminates, in reaction solution, add 100mL dehydrated alcohol, elimination iron powder, collect filtrate, concentrated near dry in Rotary Evaporators; In concentrated solution, add 30mL water, be extracted with ethyl acetate 3 times, collect organic phase, evaporate to dryness, obtains crude product DEHP-NH 2; Cross silicagel column, collect elutriant to be V/V be the chloroform/methanol wash-out phase of 5:1 ~ 4:1, elutriant is concentrated into dry, obtains the reduzate DEHP-NH of purifying 2.
Take 1mmoL DEHP-NH 2(406mg) round-bottomed flask is placed in 2mmoL sodium chloroacetate (0.232g), and by the anhydrous alcohol solution of its mixture 10mL, the 0.276g salt of wormwood simultaneously added, back flow reaction at 60 DEG C, appropriate potassiumiodide is added as catalyzer in reaction process, after return stirring reaction 5h, stopped reaction.Filter reaction mixture and obtain yellowish brown filtrate, concentrate and obtain brown color grease-like material.Cross silicagel column, collect elutriant to be V/V be the chloroform/methanol wash-out phase of 4:1 ~ 5:1, elutriant is concentrated into dry, obtains product and is target haptens.
Embodiment 2
The synthesis of artificial antigen
The synthesis of 2.1 immunizing antigens and purifying:
Immunizing antigen adopts active ester method.The DEHP haptens of 50 μm of ol is dissolved in the DMF of 1mL, then in this solution, equimolar DCC and NHS is added, the reaction of room temperature lucifuge is spent the night, 4 DEG C of centrifugal segregation precipitations, get supernatant liquor, and it slowly being joined in the carbonic acid buffer of 5mL pH9.5, its damping fluid contains carrier proteins BSA, and wherein the concentration of carrier proteins is 10mg/mL.Mixture is reacted at 4 DEG C and spends the night, after question response completes, load dialysis tubing, then use the normal saline dialysis 3d of 0.9%.The solution obtaining having dialysed is artificial immunization antigen DEHP-BSA.
The synthesis of 2.2 envelope antigens and purifying:
Envelope antigen adopts mixed anhydride method.Be dissolved in 1mL DMF by 0.1mmol DEHP haptens, add the positive Tributylamine of 80 μ L, slowly drip 0.15mmol isobutyl chlorocarbonate under ice bath, 4 DEG C of stirring reaction 1h, this is first liquid.Be dissolved in the sodium bicarbonate buffer liquid of 5mL1mol/L pH9.6 by 60mg carrier proteins OVA, this is second liquid.Slowly be added drop-wise to by first liquid in second liquid, 4 DEG C of magnetic agitation reactions are spent the night, and after question response completes, load dialysis tubing, then use the normal saline dialysis 3d of 0.9%.The solution obtaining having dialysed is artificial envelope antigen DEHP-OVA.
Embodiment 3:
The qualification of artificial antigen:
According to the obtained the maximum absorption of spectrophotometry haptens, carrier proteins and conjugate, calculate the coupling ratio of conjugate.Scan raw material, BSA, OVA and conjugate ultra-violet absorption spectrum respectively between 200-400nm, whether qualification haptens and carrier proteins there is coupling.Estimate haptens and carrier protein couplet ratio, result is as follows as calculated: DEHP-BSA is 18.5:1, DEHP-OVA is 6.8:1 simultaneously.
Although preferred embodiment of the present invention has disclosed as above, the present invention has been not limited to above-described embodiment, any those skilled in the art, not departing from the scope disclosed by the present invention, when doing a little change and adjustment.

Claims (6)

1. a DEHP haptens, is characterised in that molecular structural formula is:
N is the natural number of 1 ~ 6.
2. a DEHP artificial antigen, is be combined into by DEHP haptens according to claim 1 and carrier proteins, it is characterized in that: described DEHP artificial antigen molecular structural formula is:
N is the natural number of 1 ~ 6; Described carrier proteins is bovine serum albumin, ovalbumin or hemocyanin.
3. the haptenic synthetic method of DEHP as claimed in claim 1, is characterized in that comprising the following steps:
(1) be that concentrated nitric acid and DEHP are placed in round-bottomed flask by 3:1 by feed ratio, be added drop-wise to 2 times under condition of ice bath in the vitriol oil of concentrated nitric acid amount, magnetic agitation, reacts to room temperature, then 60 DEG C of back flow reaction 5h, and period is monitored with TLC.With the sodium hydroxide solution neutralization reaction liquid of 1moL/L to weakly alkaline, extraction into ethyl acetate 3 times, organic phase evaporated under reduced pressure on Rotary Evaporators obtains thick nitration product DEHP-NO 2, cross silicagel column, collect elutriant to be V/V be the chloroform/hexanaphthene wash-out phase of 2:1 ~ 3:1, elutriant is concentrated into dry, obtains the nitration product DEHP-NO of purifying 2;
(2) be that 1:2:2 is by DEHP-NO by feed ratio 2, NH 4cl, iron powder are placed in round-bottomed flask, and add in 70% appropriate ethanolic soln, magnetic agitation, 50 DEG C of back flow reaction 5h, period is monitored with TLC; After reaction terminates, in reaction solution, add 100mL dehydrated alcohol, elimination iron powder, collect filtrate, concentrated near dry in Rotary Evaporators; In concentrated solution, add 30mL water, be extracted with ethyl acetate 3 times, collect organic phase, evaporate to dryness, obtains crude product DEHP-NH 2; Cross silicagel column, collect elutriant to be V/V be the chloroform/methanol wash-out phase of 5:1 ~ 4:1, elutriant is concentrated into dry, obtains the reduzate DEHP-NH of purifying 2;
(3) be that 1:2 ~ 1:3 is by DEHP-NH by feed ratio 2round-bottomed flask is placed in halo hydrochlorate, and by a small amount of anhydrous alcohol solution of its mixture, add the salt of wormwood with halo hydrochlorate equivalent simultaneously, back flow reaction at 60 DEG C, appropriate potassiumiodide is added as catalyzer in reaction process, after return stirring reaction 5h, stopped reaction, filter reaction mixture and obtain yellowish brown filtrate, concentrated obtain brown color grease-like material, cross silicagel column, to collect elutriant be V/V is the chloroform/methanol wash-out phase of 4:1 ~ 5:1, elutriant is concentrated into dry, obtains product and is target haptens.
4. the haptenic synthetic method of DEHP according to claim 3, it is characterized in that: described halo hydrochlorate is halogenated acid sodium, its structural formula is R-(CH 2) n-COONa, wherein R can be Cl or Br, n=1 ~ 6.
5. the preparation method of DEHP artificial antigen is active fat method and mixed anhydride method as claimed in claim 2, it is characterized in that:
Described active ester method is:
(1) be dissolved in the DMF of 1mL by the DEHP haptens of 0.1mmol, then in this solution, add equimolar DCC and NHS, the reaction of room temperature lucifuge is spent the night;
(2) 4 DEG C of centrifugal segregation precipitations, get supernatant liquor, and it slowly joined in the carbonic acid buffer of 5mL pH9.5, its damping fluid contains carrier proteins BSA or OVA, and wherein the concentration of carrier proteins is 10 ~ 15mg/mL, reacts and spend the night at 4 DEG C;
(3) reaction solution in step (2) is loaded dialysis tubing, with the normal saline dialysis 3d of 0.9%, obtain artificial antigen;
Described mixed anhydride method is:
(1) be dissolved in 1mL DMF by 0.1mmol DEHP haptens, add the positive Tributylamine of 80 μ L, slowly drip 0.15mmol isobutyl chlorocarbonate under ice bath, 4 DEG C of stirring reaction 1h, this is first liquid;
(2) be dissolved in the sodium bicarbonate buffer liquid of 5mL1mol/L pH9.6 by 60mg carrier proteins BSA or OVA, this is second liquid;
(3) be slowly added drop-wise in second liquid by first liquid, 4 DEG C of magnetic agitation reactions are spent the night, and after question response completes, load dialysis tubing, then use the normal saline dialysis 3d of 0.9%, obtain artificial antigen.
6. the application of DEHP artificial antigen as claimed in claim 2, is characterized in that, described DEHP artificial antigen is applied to the preparation of the anti-DEHP polyclonal antibody of preparation or monoclonal antibody.
CN201410336147.8A 2014-07-15 2014-07-15 A kind of dioctyl phthalate haptens and synthesizing artificial antigen and its application Active CN104744285B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410336147.8A CN104744285B (en) 2014-07-15 2014-07-15 A kind of dioctyl phthalate haptens and synthesizing artificial antigen and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410336147.8A CN104744285B (en) 2014-07-15 2014-07-15 A kind of dioctyl phthalate haptens and synthesizing artificial antigen and its application

Publications (2)

Publication Number Publication Date
CN104744285A true CN104744285A (en) 2015-07-01
CN104744285B CN104744285B (en) 2017-10-27

Family

ID=53584642

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410336147.8A Active CN104744285B (en) 2014-07-15 2014-07-15 A kind of dioctyl phthalate haptens and synthesizing artificial antigen and its application

Country Status (1)

Country Link
CN (1) CN104744285B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107098961A (en) * 2017-06-14 2017-08-29 重庆师范大学 Triptolide artificial antigen and preparation method and polyclonal antibody
CN110272876A (en) * 2019-04-15 2019-09-24 上海交通大学 Anti- diethyl phthalate monoclonal antibody hybridoma cell strain and its construction method
CN114317447A (en) * 2021-12-10 2022-04-12 浙江树人学院(浙江树人大学) Hybridoma cell strain secreting di (2-ethylhexyl) phosphate monoclonal antibody, monoclonal antibody and application

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101328218A (en) * 2008-07-29 2008-12-24 江南大学 Preparation of diisooctyl phthalate artificial antigen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101328218A (en) * 2008-07-29 2008-12-24 江南大学 Preparation of diisooctyl phthalate artificial antigen

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHENXI WEI ET AL: "An Immunoassay for Dibutyl Phthalate Based on Direct Hapten Linkage to the Polystyrene Surface of Microtiter Plates", 《PLOS ONE》 *
MING-CUI ZHANG ET AL: "A novel competitive fluorescence immunoassay for the determination of dibutyl phthalate", 《ANAL BIOANAL CHEM》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107098961A (en) * 2017-06-14 2017-08-29 重庆师范大学 Triptolide artificial antigen and preparation method and polyclonal antibody
CN110272876A (en) * 2019-04-15 2019-09-24 上海交通大学 Anti- diethyl phthalate monoclonal antibody hybridoma cell strain and its construction method
CN114317447A (en) * 2021-12-10 2022-04-12 浙江树人学院(浙江树人大学) Hybridoma cell strain secreting di (2-ethylhexyl) phosphate monoclonal antibody, monoclonal antibody and application
CN114317447B (en) * 2021-12-10 2023-09-08 浙江树人学院(浙江树人大学) Hybridoma cell strain secreting di (2-ethylhexyl) phosphate monoclonal antibody, monoclonal antibody and application

Also Published As

Publication number Publication date
CN104744285B (en) 2017-10-27

Similar Documents

Publication Publication Date Title
CN101865924B (en) Method for detecting fumonisins based on immuno-magnetic bead combined enzyme-linked immunosorbent assay
CN104327183B (en) A kind of paclobutrazol artificial antigen and preparation method and the application of polyclonal antibody
CN104447383B (en) A kind of Dihydrocapsaicin artificial semiantigen, artificial antigen and preparation method thereof
CN101962358A (en) Ciprofloxacin hapten, artificial antigen and antibody and preparation method and application thereof
CN105481859B (en) A kind of artificial antigen, antibody and its enzyme-linked immunologic detecting kit of tadalafil and its analogue
CN105503632B (en) It is a kind of to be provided commonly for detecting crystal violet and haptens, the preparation method and applications of artificial antigen of malachite green
CN101799472A (en) Diethylstilbestrol detection kit and detection method
CN107422112B (en) It is a kind of to detect the immune reagent kit of ethopabate, preparation method and application
CN102796102B (en) Caffeine haptens, conjugate and application, caffeine detection or measuring method
CN104744285A (en) Synthesis method for dioctyl phthalate hapten and artificial antigen and application thereof
CN106771137A (en) Detect enzyme linked immunological kit and its application of Nicarbazin
CN105301252A (en) Immunomagnetic bead for enrichment and purification of ochratoxin A, and preparation method and application of immunomagnetic bead
CN101871936A (en) Rhodamine B ELISA detection method
CN102816196A (en) Tildipirosin hapten and artificial antigen as well as preparation methods thereof
CN104744294B (en) (α ethyl hexyls) ester hapten, artificial antigen and its preparation method for antibody of phthalic acid two and application
CN105277423A (en) Immunomagnetic bead used for vomitoxin enrichment purifying and preparation method and application thereof
CN102478578A (en) Chemiluminescent kit for assaying zearalenone and preparation method thereof
CN102336831A (en) Anti-sildenafil specific antibody
CN105004844B (en) A kind of gentamicin residue test strip and application thereof
CN103389373B (en) A kind of test paper and application thereof detecting sulfa drugs
CN102875512B (en) Preparation method of anticoagulant raticide brodifacoum hapten and holoantigen
CN103105490B (en) A kind of kit and method detecting tetracycline medication
CN110981875A (en) Atropine hapten, synthetic method thereof, antigen, antibody and application
CN102295698B (en) Cyclosporine A immunogen, cyclosporine A specific antibody, detection reagent, and detection kit
CN103073633A (en) Antibody against 5-hydroxymethyl furfural

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant